… reveal the factors leading to … Finland, they have been sold as OTC medicine in different
sale outlets, including food stores, gas stations and kiosks, since 2006. Since their deregulation …

… 26% of genes linked to cancer development are deregulated both … , nicotine products are
not subject to pharmaceutical law, but … In Finland a strategy was proposed to become not only …

… population via deregulating the current pharmacy system? … were nicotine replacement
therapy (23%), digestive medicine (… that deregulating medicine pricing would cause prices to …

… In Finland, community pharmacies have remained the sole … nicotine replacement therapies
released to open sale in 2006 [37]. Pharmacy operations are subject to licensing; a pharmacy …

… While national Kanta functions well, local patient information systems cause … of nicotine
replacement therapies that were released to open market in 2006. , 25 Community pharmacy is …

… reference pricing on market structure in order to study if the decreased prices cause fewer
… the exception of nicotine products, which were deregulated in 2006 in Finland and can be …

… motives, and smoking cessation behaviours were utilised in descriptive analyses of relationships
between vaping … With the deregulation in the wake of TPD as a backdrop, knowledge …

… This paper focuses on the possible reasons for retaining national … movement towards
deregulation, which has marked neoliberal … in Finland, with a small percentage of medicinal use. …

… The main arguments favoring deregulation have been … of factors crucial for determining
pharmacy business in Finland. On the other hand, three of the factors influenced active product …

… There is nothing to be ashamed of buying nicotine gum.” – DCC … This study shows that
analysis of arguments can nuance pharmaceutical policy analyses. Arguments are the …